Skip to main content
Equibles

CENTAURUS FINANCIAL, INC.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 891943 ANAHEIM, CA
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,181,768
-$29,869 QoQ
Shares Held
34,881
-13.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#323
of 676 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CENTAURUS FINANCIAL, INC. holds $2,658,245 across 7 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (44.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page 		34,881 $1,181,768
2 LNTH
Lantheus Holdings, Inc.
 6,015 $667,304
3 ALKS
Alkermes plc.
 5,811 $304,496
4 ZTS
Zoetis Inc.
 2,510 $180,368
5 TRLV
Trulieve Cannabis Corp.
 16,592 $163,099
6 LQDA
Liquidia Corp
 1,300 $103,649
7 TLRY
Tilray Brands, Inc.
 12,820 $57,561

All Filings in TEVA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,181,768 34,881
2026-03-31 $1,211,637 40,227
2025-12-31 $1,383,601 44,332
2025-09-30 $1,042,562 51,612
2025-06-30 $690,981 41,228
2025-03-31 $689,405 44,854
2024-12-31 $777,549 35,279
2024-09-30 $322,395 17,891
2024-06-30 $227,743 14,015
2023-03-31 $110,164 12,448
2022-12-31 $133,544 14,643
2022-09-30 $118,604 14,697
2022-06-30 $109,987 14,626
2022-03-31 $140,906 15,006
2021-12-31 $136,218 17,006
2021-09-30 $158,820 16,306
2021-06-30 $166,379 16,806
2021-03-31 $190,456 16,504
2020-12-31 $100,253 10,389
2020-09-30 $97,208 10,789
2020-06-30 $133,028 10,789
2020-03-31 $96,957 10,797